Chiron Real Estate Inc is a real estate investment trust focused on investing and actively managing critical healthcare infrastructure... Show more
a company, which engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups
Industry PublishingBooksMagazines
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| USPFX | 35.93 | 0.11 | +0.31% |
| Union Street Partners Value Advisor | |||
| MDRFX | 23.87 | 0.06 | +0.25% |
| BlackRock Mid-Cap Value Investor A | |||
| FACSX | 56.59 | N/A | N/A |
| Nuveen Mid Cap Value Opportunities C | |||
| JVMCX | 28.06 | N/A | N/A |
| JHancock Disciplined Value Mid Cap C | |||
| CBHIX | 9.37 | N/A | N/A |
| Victory Market Neutral Income I | |||
A.I.dvisor indicates that over the last year, XRN has been loosely correlated with UDR. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if XRN jumps, then UDR could also see price increases.
| Ticker / NAME | Correlation To XRN | 1D Price Change % | ||
|---|---|---|---|---|
| XRN | 100% | -1.02% | ||
| UDR - XRN | 61% Loosely correlated | -0.75% | ||
| STAG - XRN | 59% Loosely correlated | -0.18% | ||
| IRT - XRN | 59% Loosely correlated | -0.66% | ||
| ESS - XRN | 59% Loosely correlated | -0.29% | ||
| DBRG - XRN | 59% Loosely correlated | +0.25% | ||
More | ||||
XRN saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on June 16, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 37 instances where the indicator turned negative. In of the 37 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 53 cases where XRN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XRN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
XRN broke above its upper Bollinger Band on May 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for XRN entered a downward trend on May 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Momentum Indicator moved above the 0 level on June 09, 2026. You may want to consider a long position or call options on XRN as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
XRN moved above its 50-day moving average on May 19, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for XRN crossed bullishly above the 50-day moving average on May 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XRN advanced for three days, in of 291 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.230) is normal, around the industry mean (2.701). XRN has a moderately low P/E Ratio (0.000) as compared to the industry average of (58.034). XRN's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (3.232). XRN's Dividend Yield (0.172) is considerably higher than the industry average of (0.059). P/S Ratio (3.087) is also within normal values, averaging (6.204).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. XRN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 65, placing this stock slightly better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.